VO659 is an antisense oligonucleotide being investigated for the treatment of Huntington's disease.
VO659 is an antisense oligonucleotide being investigated for the treatment of Huntington's disease.
No indication information available.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.